Gilead Sciences Inc

GILD•United States

Healthcare United States Biological ProductsOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$138.11

+0.66%

End of day

Market Cap

$189.22B

P/E Ratio

23.57

Employees

N/A

Dividend Yield

2.10%

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	2.33	2.70	1.68	—	2.18
Calmar	—	—	3.73	3.85	2.27	—	3.16
Sharpe	—	—	1.39	1.66	1.06	—	1.34
Omega	—	—	1.27	1.30	1.20	—	1.25
Martin	—	—	11.50	12.88	6.74	—	9.98
Ulcer	—	—	3.87	3.57	4.64	—	4.09

Also Listed On

GIS.XETRA

XETRA (Frankfurt) · EUR

$157.66B

Gilead Sciences Inc (GILD) Price Performance

Gilead Sciences Inc (GILD) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $138.11, up 0.66% from the previous close.

Over the past year, GILD has traded between a low of $94.94 and a high of $155.80. The stock has gained 29.0% over this period. It is currently 11.4% below its 52-week high.

Gilead Sciences Inc has a market capitalization of $189.22B, with a price-to-earnings ratio of 23.57 and a dividend yield of 2.10%.

Company Info

Sector: Healthcare
Industry: Biological Products
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $27.12B
EBITDA: $14.14B
Profit Margin: 27.88%
EPS (TTM): 4.55
Book Value: 17.34

Technical Indicators

52 Week High: $157.29
52 Week Low: $91.47
50 Day MA: $126.97
200 Day MA: $116.53
Beta: 0.39

Valuation

Trailing P/E: 23.57
Forward P/E: N/A
Price/Sales: 6.51
Price/Book: 8.60
Enterprise Value: $202.91B